Aim: Whole exome sequencing (WES) is a recently developed method for discovering rare mutations associated with hereditary disorders. However, the feasibility and utilization of this method in identifying familial hypertriglyceridemia is not well known. The purpose of the study was to identify the genetic locus that causes hypertriglyceridemia and assess its prevalence in Taiwanese subjects with hypertriglyceridemia. Methods: We performed WES among two individuals with hypertriglyceridemia and one control subject in an index family (22 members). Based on the WES findings, we extended the study to genotype 65 unrelated adult index patients with a fasting serum triglyceride level of 500 mg/dL and 125 normal controls using polymerase chain reaction. Results: Using WES alignment, variant calling and annotation, 15 presumptive causal variants were initially identified, including 13 cases by the autosomal dominant model and two cases by the autosomal recessive model. Only APOA5 c.553 G T (rs2075291), resulting in the amino acid mutation Gly185Cys, co-segregated well with hypertriglyceridemia in terms of autosomal recessive inheritance (homozygote TT: mean triglyceride level: 1,071 mg/dL vs non TT (GT and GG): mean triglyceride level: 118 mg/dL; p 0.001) in the index family. In the unrelated cohorts, the frequency of the TT genotype of rs2075291 was 12.3% in the hypertriglyceridemic group; however, no TT genotype was found in the control group. Conclusions: Our results demonstrate that WES is feasible for identifying the genetic locus that causes hypertriglyceridemia. The TT genotype of APOA5 c.553G T acts as an important indicator of hypertriglyceridemia in patients in Taiwan. Advance Publication Journal of Atherosclerosis and Thrombosis Accepted for publication: February 17, 2015 Published online: April 4, 2015 2 mutations in each candidate gene has been performed using a Sanger-based sequencing strategy This approach is used to screen a number of genes, including the LPL, APOC2, LMF1, APOA5 and GP1HBP1 genes, followed by AGPAT2, APOE, PPARG, AKT2 and USF1. At present, screening multiple genes is time-consuming and expensive and is a limitation to the identification of HTG-associated loci for personalized health management. Whole exome sequencing (WES) has emerged as a successful tool for detecting single-nucleotide substitutions and insertions as well as small deletions up to 10 nucleotides 14) . This technique has enabled the novel identification and molecular characterization of genetic defects in a wide spectrum of rare and genetically heterogeneous Mendelian disorders [14] [15] [16] [17] . However, the feasibility and utilization of this method for identifying familial HTG is not well known [18] [19] [20] . Accordingly, the aims of this study were: 1) to test the hypothesis that WES can be used to identify the causative gene in patients with clinical manifestations of the familial form of HTG and 2) to use these findings to explore the prevalence of adults with very high TG levels among Taiwanese   21) .
Introduction
A very high triglyceride (TG) level is defined as a fasting serum TG level of 500 mg/dL and is prevalent in approximately 1% of the adult population worldwide 1, 2) . This finding is a well-established cardiovascular risk factor that is independent of highdensity lipoprotein cholesterol (HDL-C). Recent progress in human genetics has furthered our understanding of the genetic susceptibility to hypertriglyceridemia (HTG), which can be attributed to either monogenic dyslipidemia or complex diseases with strong polygenic components 3, 4) . Currently, more than 30 candidate genes have been reported to be associated with HTG [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] . The prevalence of each causative gene is different among multiethnic populations, and the differences in functional variants are specific to ethnic groups. The expanding list of disease loci makes confirming the genetic diagnosis in cases of HTG challenging. Traditionally, ad hoc screening for causative 2 mutations in each candidate gene has been performed using a Sanger-based sequencing strategy This approach is used to screen a number of genes, including the LPL, APOC2, LMF1, APOA5 and GP1HBP1 genes, followed by AGPAT2, APOE, PPARG, AKT2 and USF1. At present, screening multiple genes is time-consuming and expensive and is a limitation to the identification of HTG-associated loci for personalized health management. Whole exome sequencing (WES) has emerged as a successful tool for detecting single-nucleotide substitutions and insertions as well as small deletions up to 10 nucleotides 14) . This technique has enabled the novel identification and molecular characterization of genetic defects in a wide spectrum of rare and genetically heterogeneous Mendelian disorders [14] [15] [16] [17] . However, the feasibility and utilization of this method for identifying familial HTG is not well known [18] [19] [20] . Accordingly, the aims of this study were: 1) to test the hypothesis that WES can be used to identify the causative gene in patients with clinical manifestations of the familial form of HTG and 2) to use these findings to explore the prevalence of adults with very high TG levels among Taiwanese 21) .
Methods

Study Design and Subjects
First, WES was performed to identify the causative gene in two affected individuals and a normal individual from the index family. Second, allelic discrimination of the causative gene was identified using polymerase chain reaction (PCR) in an extended cohort consisting of 65 unrelated adult patients with very high TG levels, namely an overnight fast-serum TG level of 500 mg/dL, after a 12-week low-fat diet and the exclusion of the following factors: diabetes mellitus, hypothyroidism, liver and kidney disease, drugs known to interfere with lipid metabolism, alcohol drinking, a body mass index (BMI) of 30 kg/m 2 or a age younger than 18 years. The 125 age/sexmatched control group included healthy, non-smoking subjects with a serum TG level below 150 mg/dL. The purpose of the study was carefully explained to all participants, and written informed consent was obtained prior to participation. The Institutional Review Board of our hospital provided ethics approval of the study protocol, which was carried out according to the principles of the Helsinki Declaration.
Biochemical Analyses and DNA Extraction
Blood samples were collected after an overnight fast for the lipid analysis. The total serum cholesterol, TG, HDL-C and low-density lipoprotein cholesterol (LDL-C) levels were determined using commercial kits (Wako, Osaka, Japan) on a Hitachi 7600 clinical analyzer (Hitachi High-Tech, Tokyo, Japan). If the TG level was 1,000 mg/dL, the quantitative determination of the HDL-C and LDL-C levels was also corrected for measurements obtained using commercial kits (SPIFE Vis Cholesterol System, Beaumont, Texas) on a Helena SPIFE 3000 device (Helena Laboratories, Beaumont, Texas). Genomic DNA of leukocytes was extracted using the DNA Midi Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions.
Whole Exome Sequencing, Alignment, Variant Calling and Annotation
Two affected individuals (I-1, I-3) and a normal control subject (I-4) from distinct branches of the family (see Supplementary Fig. 1 ) were selected for exome sequencing. DNA was fragmented and enriched for coding exons using the Illumina TruSeq Exome Enrichment Kit for samples (Illumina Inc., San Diego, CA) to generate exome libraries. The libraries were sequenced on an Illumina GAIIx (Illumina Inc., San Diego, CA) with 101-bp paired-end reads, according to the manufacturer's instructions. The image analysis and base calling were processed with the Sequence Control Software with Real-Time Analysis (Illumina) and CASAVA software (Illumina) programs.
The paired sequencing reads were first aligned to the human reference genome reference assembly GRCh37 using a Burrows-Wheeler Aligner 22) . The post-alignment process, including SAM conversion, sorting and PCR duplicate removal, was performed using Picard (http://picard.sourceforge.net/) and SAMtools (http://samtools.sourceforge.net/). The Genome Analysis Toolkit (GATK) was then used to process local realignment around small insertions-deletions (INDELs) and for Base Quality Score Recalibration 23) . For each sample, a processed alignment file was saved in bam format.
In order to identify Single Nucleotide Variants (SNVs) and INDELs, we subsequently performed GATK pipeline, followed by Variant Quality Score Recalibration. The SNVs and INDELs were then annotated via the Variant Effect Predictor to record, for example, the position in the genes and amino acid changes relative to the human Refseq genome, the consequence of the mutation (i.e., non-synonymous, nonsense, etc.). All added annotations were saved in a database including dbSNP, PolyPhen2, SIFT and COSMIC [24] [25] [26] [27] 3 between the groups; 2) both a SIFT score of ≤ 0.05 and Polyphen-2 score of ≥ 0.2; 3) a minor allele frequency of ≤ 0.05 from the 1,000 Genome ASN population; and 4) containing Variant Clinical Significance annotations.
Both inheritance patterns, namely autosomal dominant vs. autosomal recessive, were analyzed. Candidate genes were acquired using DAVID (http:// david.abcc.ncifcrf.gov/) and Gestalt (http://bioinfo. vanederbilt.edu/webgestalt/), which allowed the genes to be clustered based on function and different gene ontologies. Moreover, the Pathway Interaction Database (PID) (http://pid.nci.nih.gov/) and IPA (Ingenuity ® Systems, www.ingenuity.com) defined the genes based on the pathway interactions.
Genotyping
In order to confirm the causative mutations identified using the WES analysis, the causative gene was amplified via PCR and sequenced according to Sanger sequencing (3130xL Genetic Analyzer, Applied Biosystems, Foster City, CA) using DNA collected from index family members. For the analysis of the genotype of the causative gene, allelic discrimination of the SNPs was performed in individuals from the index family and the extended cohort.
Statistical Analysis
The frequencies of the alleles were calculated with gene counting. The statistical analysis was performed using the SPSS software program version 10.0 for Windows (SPSS Inc., Chicago, USA). Genotype frequencies with Hardy-Weinberg equilibrium expectations were tested using Fisher's exact test. Differences in quantitative variables were calculated according to the Student's unpaired t -test, and the difference in the serum triglyceride levels among each genotype was tested using an analysis of variance (ANOVA). All p values were two-tailed, and p values of 0.05 were considered to be statistically significant.
Results
Characteristics and Exome Sequencing of the Index Family
The characteristics of the index family are shown in Fig. 1 and included age, sex and lipid profiles available for 22 members. Members of the index family did not have any secondary causes of HTG, were healthy and did not suffer from cardiovascular events or acute pancreatitis. The TG levels in the family pedigree fit the clinical diagnosis of the familial form of HTG ( Fig. 1) . All four HTG members received TGlowering medications (fenofibrate at 200 mg and acipimox at 500 mg per day), with a post-treatment TG level of around 220-300 mg/dL. Three DNA samples, two from HTG patients (I-1, I-3) and one from a normal family member (I-4), were examined using WES. The coverage and coverage statistics are summarized in Table 1 . All variations were compared with those available in SNP databases, resulting in the identification of 55613, 55000 and 55692 SNPs for I-1, I-3 and I-4, respectively. First, we used the autosomal dominant model to analyze the variants. A total of 66 SNPs were initially detected, including 57 known SNPs and nine de novo variations (see Supplementary  Table 1 ). Under the IPA Gene View, which demonstrated the protein function, biologic process, canonical pathway and top findings from the Ingenuity Knowledge Base, genes having a possible direct/indirect interaction with either lipids, endocrine factors, energy and/or metabolism, were selected as candidate genes. In total, 13 candidate genes were acquired (see Supplementary Table 2 ). In addition, these genes were analyzed using IPA; the prediction network is shown in Supplementary Fig. 2 . None of the gen es co-segregated with HTG in the index family. Second, we used the autosomal recessive model to analyze the variants, and two missense variants were detected between the groups (see Supplementar y Table 3) . Only one variant, APOA5 c.553G T (rs2075291), which resulted in the amino acid substitution Gly185Cys, co-segregated with HTG in the affected family members (homozygote TT, mean triglyceride level: 1,071 mg/dL vs non TT (GT and GG): mean triglyceride level: 118 mg/dL; p 0.001 (Fig. 1) . Additional variants were not identified in any of the other candidate genes. Finally, Sanger sequencing of genomic DNA from all individuals in the index family confirmed that missense mutations in APOA5 exon four co-segregated with HTG via an autosomal recessive mode of inheritance.
rs2075291 Genotyping in the Extended Cohort
A further survey of the prevalence of severe HTG adult patients carrying the APOA5 c.553G T mutation was performed. Table 2 shows the general characteristics and genotypes of the index patients with severe HTG (65) and the age-matched control (125) subjects. The frequencies of the GG, GT and TT genotypes were 55.4%, 32.3% and 12.3%, respectively, in the HTG group, In the control group, the frequencies were 87.2% and 12.8% for the GG and GT genotypes, respectively. The TT genotype was not found in any individuals in the control group.
Discussion
Using WES, we confirmed that the APOA5 TT genotype (rs2075291) is a causative mutation that cosegregates with HTG in an index family. The prevalence of this genotype was also high in the extended cohort. In contrast, none of the unaffected family members or normal individuals in the control group had the TT genotype in the of rs2075291 variant of APOA5. Our findings demonstrate the effectiveness of WES in providing a molecular diagnosis of familial HTG. We performed a WES analysis to selectively sequence only the coding regions and neighboring intron-exon boundaries of the individual human genome in order to identify the causative mutation. Basing our analysis on an autosomal recessive mode of inheritance, the APOA5 c.553G T (rs2075291) SNP variant was found to be co-segregated with HTG (Fig. 1) . According to the autosomal dominant mode of inheritance, 13 SNPs (Supplementary Table 2) were presumptive candidate genes. The prediction network (Supplementary Fig. 2) showed that APOB might be related to TNF-a, P2RY6 and NFkB, located in the extracellular region, plasma membrane and nucleus, respectively. After confirming the genotypes of all index family members using Sanger sequencing, we found that none of the 13 SNPs co-segregated with HTG.
A genetic diagnosis is the gold standard for identifying familial HTG. Techniques for obtaining a genetic diagnosis are clinically relevant, especially for screening the family members of affected individuals. However, each technique has a unique set of technical, financial and throughput limitations. Although a genome-wide association study (GWAS) can be used to identify DNA sequences as determinants of the plasma TG concentration 4, 11) . whether these sequences lie within genomic regions containing classically established genes and/or previously uncharacterized regions, this technique cannot be employed to assign causation to a particular gene or variant. Complementary experimental approaches, including rare variant sequencing, animal models studies, linkage and family-based studies and functional cellular and biochemical experiments, are required to more fully elucidate the genetic architecture of the plasma TG concentration.
Currently, WES can be utilized to detect rare variants in patients with a phenotype that is suspected to be a Mendelian (single-gene) genetic disorder, after known single-gene candidates have been eliminated or when testing multiple genes is prohibitively expensive 12) . The limitation of WES is that this technique only allows for the identification of those variants found in coding regions and that affect the protein function. WES does not allow for the identification of structural and non-coding variants associated with the disease. These types of variants can be detected using other methods, such as whole genome sequencing, as a back-up measure if the results of exome sequencing are negative. With continuing improvements and decreasing costs, WES or targeted WES may have advantages over current Sanger-based clinical resequencing strategies for patients with HTG.
The human APOA5 gene is located within the APOA1/C3/A4/A5 gene cluster, a short region on chromosome 11q23-q24, and is a member of the apolipoprotein gene family. APOA5 has previously been identified to be a key regulator of the serum TG concentration 28, 29) . APOA5 indirectly regulates TG metabolism by stimulating the lipoprotein lipase (LPL) activity, which increases the rate of LPL-mediated TG hydrolysis 30) . In previous genotyping and haplotyping studies, the APOA5 gene was reported to be associated with an elevated TG level; however, the clinical significance and prevalence varied among different ethnici- [31] [32] [33] [34] [35] [36] [37] [38] [39] . In Taiwan, two haplotypes of APOA5 (rs662799 and rs2075291) have been found to be closely related to HTG 39) . Moreover, the TT genotype of rs2075291 in the Taiwanese population was reported to be associated with HTG by Kao J. et al. In that report, the frequency of the TT genotype of rs2075291 was reported to be 8.7% in the HTG group 40) . Based on these previous studies, SNP rs2075291 (553G T) is closely associated with HTG. Hung et al. used site-directed mutagenesis to introduce C553G T in vitro, which reduced the activation of LPL-mediated hydrolysis of very low-density lipoprotein to levels that ranged from 31% to 81% of wild-type APOA5 41) . Even with these data, it is still uncertain whether the SNP rs2075291 (C553G T) is a definitive causative mutation. According to our WES findings, APOA5 C553G T (rs2075291) is a causative gene mutation. Additionally, in agreement with the findings of a previous report 40) , the prevalence of the TT genotype (rs2075291) is high in affected Taiwanese populations. According to the ExAC browser (http://exac.broadinstitute.org/), which contains exome sequence data for 61,486 individuals as a global "reference set," there are 26 individuals with homozygous mutations with rs2075291 (allele frequency: 0.00637). However, in the reference set, individuals with severe pediatric diseases were removed. In our study, the enrolled patients had very high TG levels and were adults ( 18 years old). The homozygous mutation may predispose adults, not children, to a very high TG level. Additionally, the majority of homozygous mutations were found in East Asians, not in the Caucasian population, in the reference set. The higher frequency of this mutation in our extended cohort highlights the importance of primary HTG in East Asians, including Japanese, Chinese, Koreans, etc. More studies are needed to better understand these issues in terms of clinical practice.
The following limitations of the study should be acknowledged: First, this study did not measure the plasma APOA5 level, LPL mass or post-heparin LPL activity in the index family members or extended cohort, which provides a direct link to this mutation in TG metabolism. Additional investigations are needed to understand the role of the APOA5 protein level and LPL lipase mass/activity modulated by this mutation. Second, besides APOA5 c.553 G T, mutations of other genes, such as LPL, apo C-and so on, which were not investigated in this study, may also have contributed to the development of a high triglyceride level in the 65 primary HTG patients.
In conclusion, this study demonstrated that WES is feasible for identifying the genetic locus that causes HTG. Furthermore, the TT genotype of APOA5 c.553G T acts as an important indicator for recognizing hypertriglyceridemic patients in Taiwan. Therefore, continuing efforts to investigate regional founder effects and gain insights into the evolution of the TT genotype (rs2075291) in East Asians would be worthwhile.
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